Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2009-01-13

Clinical Trial Update: Effect of Green Tea Extract on Type 2 Diabetes [Phase 2, Phase 3]

View source ↗

Summary

This update notes that Phase 2 and Phase 3 trials evaluating green tea extract for Type 2 diabetes mellitus have been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Green Tea Extract (Camellia sinensis extract)

Snippet

Sponsor: Taipei Hospital, Taiwan | Conditions: Type 2 Diabetes | Phase 2, Phase 3 | Status: COMPLETED